Efficacy of sertraline plus placebo or add-on celecoxib in major depressive disorder: macrophage migration inhibitory factor as a promising biomarker for remission after sertraline—results from a randomized controlled clinical trial

HIGHLIGHTS

• who: Maria S. Simon from the Jiaotong University, China have published the Article: Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial, in the Journal: (JOURNAL) of 08/Oct/2020
• what: This study aimed to find potential biomarkers that may enable patients to be stratified according to immune activation. This study provides novel insights by suggesting macrophage migration inhibitory factor as a promising biomarker for treatment choice.
• how: The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.